| Literature DB >> 20429906 |
Peter O Ouma1, Anna M van Eijk, Mary J Hamel, Evallyne S Sikuku, Frank O Odhiambo, Kaendi M Munguti, John G Ayisi, Sara B Crawford, Piet A Kager, Laurence Slutsker.
Abstract
BACKGROUND: Maternal mortality remains high in developing countries and data to monitor indicators of progress in maternal care is needed. We examined the status of maternal care before and after health care worker (HCW) training in WHO recommended Focused Antenatal Care.Entities:
Year: 2010 PMID: 20429906 PMCID: PMC2867783 DOI: 10.1186/1742-4755-7-1
Source DB: PubMed Journal: Reprod Health ISSN: 1742-4755 Impact factor: 3.223
Figure 1Antenatal attendance in Kenya from 1993-2005.
Services offered in the ANC among attending women Asembo/Gem 2005 and 2002.
| Asembo 2005 | Gem 2005 | Asembo 2002 | Gem 2002 | |
|---|---|---|---|---|
| Services | n (%) | n (%) | n (%) | n (%) |
| Palpation of abdomen | 238/241 (98.8) | 381/384 (99.2) | 290/292 (99.3) | 272/278 (97.8) |
| Listen to foetal heart rate | 233/241 (96.7) | 377/384 (98.2) | NA | NA |
| Tetanus vaccination | 232/242 (95.9) | 361/382 (94.5) | 282/292 (96.6) | 273/278 (98.2) |
| Weight measurement | 191/241 (79.3)* | 377/384 (98.2) | 241/293 (82.3)* | 277/278 (99.6) |
| Iron supplementation | 197/239 (82.4)* | 260/373 (69.7) | 154/289 (53.3) | 149/277 (53.8) |
| Folic acid supplementation | 167/232 (72.0)* | 170/356 (47.8) | 153/290 (52.8)* | 100/269 (37.2) |
| SP ≥ 1 dose | 148/240 (61.7)* | 74/373 (19.8) | 58/286 (20.3) | 63/277 (22.7) |
| SP ≥ 2 doses | 67/237 (28.3)* | 14/370 (3.8) | 22/237 (9.3) | 20/357 (5.6) |
| Blood pressure measurement | 152/240 (63.3)* | 274/384 (71.4) | 198/292 (67.8) | 187/276 (67.8) |
| Test haemoglobin level | 72/237 (30.8) | 144/377 (38.2) | 148/286 (51.8) | 138/274 (48.5) |
| Urine analysis done | 73/240 (30.4)* | 88/383 (23.0) | 59/293 (20.1)* | 30/278 (10.8) |
| Stool test | 58/240 (24.2)* | 45/384 (11.7) | 50/293 (17.1)* | 22/278 (7.9) |
| Antihelminth treatment | 30/237 (12.7)* | 15/365 (4.1) | 13/283 (4.6)* | 2/268 (0.8) |
| Offered test for STD (e.g. syphilis) | 20/232 (8.6) | 45/377 (11.9) | 62/289 (21.5) | 49/277 (17.7) |
| Offered test for HIV | 26/232 (11.2)* | 139/379 (36.7) | NA | NA |
| Health talk provided | 42/240 (17.5)* | 115/382 (30.1) | 45/289 (15.6) | 35/278 (12.6) |
| Information provided on: | ||||
| Danger signs in pregnancy | 25/241 (10.4) | 44/376 (11.7) | 49/291 (16.8) | 33/276 (12.0) |
| Malaria in pregnancy | 58/241 (24.0) | 83/381 (21.8) | NA | NA |
| Birth plan discussed | 33/241 (13.7)* | 80/380 (21.1) | NA | NA |
| Danger signs during delivery | 17/241 (7.1) | 37/380 (9.7) | NA | NA |
| Danger signs after delivery | 11/240 (4.6) | 33/381 (8.7) | NA | NA |
| Breastfeeding | 36/240 (15.0)* | 85/383 (22.2) | NA | NA |
| Family planning | 18/240 (7.5)* | 97/383 (25.3) | NA | NA |
NA: Not Available SP: sulfadoxine-pyrimethamine
* p < 0.05 comparing areas in the same survey